FDA

The FDA said the proposed order is not final yet, which means companies can still market over-the-counter drugs containing oral phenylephrine for now.

Forty years after the Hatch-Waxman Act, which provided widespread access to affordable generic versions of medications, the market is struggling with persistent shortages brought about partly by low prices.

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19. That’s according to an analysis of government data by the Associated Press. The data shows roughly 2,000 drug manufacturing sites around the world have not had a Food and Drug Administration inspection for quality since before the pandemic....

Youth vaping levels fell to the lowest in a decade this year, according to a new report from the Centers for Disease Control and Prevention and the Food and Drug Administration.

Soon, doctors must tell their mammogram patients if they have dense breast tissue, a factor that can make it harder to detect breast cancer and put them at greater risk for cancer. The Food and Drug Administration released new standards in March of 2023 in an effort to help more women detect breast cancer sooner. The FDA gave providers until…

A D.C. woman who is a two-time breast cancer survivor says for a long time she didn’t know she had dense breast tissue. A new rule aims to provide more people with the knowledge about their breast density. News4’s Aimee Cho reports.

There’s a new hope for people living with the rare blood disorder hemophilia B.  The FDA recently approved a new gene therapy treatment for those who suffer from the debilitating condition.  Dave Robinson, a 61-year-old IT consultant from Falls Church, Virginia, was born with the rare genetic blood disorder caused by an insufficient level of a protein known as...

A man from Falls Church, Virginia who was born with Hemophilia B shares his reaction towards a clinical trial for a single infusion that changed the course of his life and could help others like him. News4’s Eun Yang has the story. 

The FDA says the unapproved drugs can have some dangerous side effects.

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos Therapeutics announced the FDA’s decision on Friday.

U.S. health officials have approved the first nasal spray to treat severe allergic reactions, offering an alternative to injectable products like EpiPen.

The Food and Drug Administration’s proposal to ban formaldehyde in hair care products has been pushed back once again, and the timeline for its release remains undetermined. 

Friday’s action is the government’s strongest indication yet that switching to flavored vaping can reduce the harms traditional tobacco smoking.

Juul’s nicotine products have been allowed to stay in stores pending review of its application to sell them.

A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream.

Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems.

The U.S. Food and Drug Administration recently said it’s OK for producers of yogurt to make that claim even though it’s based on limited evidence.

A bird flu outbreak in U.S. dairy cows has spread to more than two dozen herds in eight states. That comes weeks after the nation’s largest egg producer found the virus in its chickens. Health officials continue to stress that the risk to the public is low and that the U.S. food supply remains safe and stable.

Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise.

The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.